Detalles de la búsqueda
1.
Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial.
J Clin Oncol
; 40(25): 2946-2956, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35763704
2.
Clinical-pathologic characteristics and response to neoadjuvant chemotherapy in triple-negative low Ki-67 proliferation (TNLP) breast cancers.
NPJ Breast Cancer
; 8(1): 51, 2022 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35444182
Resultados
1 -
2
de 2
1
Próxima >
>>